Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...
Pfizer (NYSE:PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (NYSE:GSK) patents for its ...
RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are ...
The CDC just released new recommendations for the shot in June 2024, focusing on folks that are 60 or older, who are ...
In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...
The provincial government says they are exploring options for an adult RSV vaccination program. RSV is a respiratory virus ...
Dr. Jaunita Mora said the respiratory syncytial virus is the leading cause of infant hospitalizations. Here are the people ...
If you, for some reason, don’t get the RSV vaccine while you’re pregnant, you can (and should!) still protect your baby after ...
HealthDay News — In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV vaccine, nirsevimab, or both, according to research published in ...
The World Health Organization on Tuesday recommended vaccinating pregnant women and administering infants with an antibody to ...